|
1
|
Venter JC, Adams MD, Myers EW, Li PW,
Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al:
The sequence of the human genome. Science. 291:1304–1351. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jupe ER, Badgett AA, Neas BR, Craft MA,
Mitchell DS, Resta R, Mulvihill JJ, Aston CE and Thompson LF:
Single nucleotide polymorphism in prohibitin 3′ untranslated region
and breast-cancer susceptibility. Lancet. 357:1588–1589. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gudmundsdottir ET, Barkardottir RB, Arason
A, Gunnarsson H, Amundadottir LT, Agnarsson BA, Johannsson OT and
Reynisdottir I: The risk allele of SNP rs3803662 and the mRNA level
of its closest genes TOX3 and LOC643714 predict adverse outcome for
breast cancer patients. BMC Cancer. 12:6212012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun K and Lai EC: Adult-specific functions
of animal microRNAs. Nat Rev Genet. 14:535–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mishra PJ, Mishra PJ, Banerjee D and
Bertino JR: MiRSNPs or MiR-polymorphisms, new players in microRNA
mediated regulation of the cell: Introducing microRNA
pharmacogenomics. Cell Cycle. 7:853–858. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu C, Gong Y, Sun A, Zhang Y, Zhang C,
Zhang W, Zhao G, Zou Y and Ge J: The human MTHFR rs4846049
polymorphism increases coronary heart disease risk through
modifying miRNA binding. Nutr Metab Cardiovasc Dis. 23:693–698.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu Y, Ma H, Yu H, Liu Z, Wang LE, Tan D,
Muddasani R, Lu V, Ajani JA, Wang Y and Wei Q: The miR-184
binding-site rs8126 T>C polymorphism in TNFAIP2 is associated
with risk of gastric cancer. PLoS One. 8:e649732013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo Z, Wang H, Li Y, Li B, Li C and Ding
C: A microRNA-related single nucleotide polymorphism of the XPO5
gene is associated with survival of small cell lung cancer
patients. Biomed Rep. 1:545–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang N, Huo Q, Wang X, Chen X, Long L,
Jiang L, Ma T and Yang Q: A genetic variant in pre-miR-27a is
associated with a reduced breast cancer risk in younger Chinese
population. Gene. 529:125–130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gilam A, Edry L, Mamluk-Morag E, Bar-Ilan
D, Avivi C, Golan D, Laitman Y, Barshack I, Friedman E and Shomron
N: Involvement of IGF-1R regulation by miR-515-5p modifies breast
cancer risk among BRCA1 carriers. Breast Cancer Res Treat.
138:753–760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Linhares JJ, Azevedo M Jr, Siufi AA, de
Carvalho CV, Mdel C Wolgien, Noronha EC, Bonetti TC and da Silva
ID: Evaluation of single nucleotide polymorphisms in microRNAs
(hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast
cancer. BMC Med Genet. 13:1192012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smith RA, Jedlinski DJ, Gabrovska PN,
Weinstein SR, Haupt L and Griffiths LR: A genetic variant located
in miR-423 is associated with reduced breast cancer risk. Cancer
Genomics Proteomics. 9:115–118. 2012.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karolchik D, Barber GP, Casper J, Clawson
H, Cline MS, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L,
Haeussler M, et al: The UCSC genome browser database: 2014 update.
Nucleic Acids Res. 42(Database Issue): D764–D670. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mundy GR: Metastasis to bone: Causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hay ED: The mesenchymal cell, its role in
the embryo, and the remarkable signaling mechanisms that create it.
Dev Dyn. 233:706–720. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brinckerhoff CE and Matrisian LM: Matrix
metalloproteinases: A tail of a frog that became a prince. Nat Rev
Mol Cell Biol. 3:207–214. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao X, Lu Y, Nie Y and Fan D: MicroRNAs
as critical regulators involved in regulating
epithelial-mesenchymal transition. Curr Cancer Drug Targets.
13:935–944. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding XM: MicroRNAs: Regulators of cancer
metastasis and epithelial-mesenchymal transition (EMT). Chin J
Cancer. 33:140–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chao CH, Chang CC, Wu MJ, Ko HW, Wang D,
Hung MC, Yang JY and Chang CJ: MicroRNA-205 signaling regulates
mammary stem cell fate and tumorigenesis. J Clin Invest.
124:3093–3106. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adachi R, Horiuchi S, Sakurazawa Y,
Hasegawa T, Sato K and Sakamaki T: ErbB2 down-regulates
microRNA-205 in breast cancer. Biochem Biophys Res Commun.
411:804–808. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Orang AV, Safaralizadeh R and Feizi MA
Hosseinpour: Insights into the diverse roles of miR-205 in human
cancers. Asian Pac J Cancer Prev. 15:577–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Liao H, Deng Z, Yang P, Du N,
Zhanng Y and Ren H: miRNA-205 affects infiltration and metastasis
of breast cancer. Biochem Biophys Res Commun. 441:139–143. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu J, Mao Q, Liu Y, Hao X, Zhang S and
Zhang J: Analysis of miR-205 and miR-155 expression in the blood of
breast cancer patients. Chin J Cancer Res. 25:46–54.
2013.PubMed/NCBI
|
|
25
|
Khan S, Greco D, Michailidou K, Milne RL,
Muranen TA, Heikkinen T, Aaltonen K, Dennis J, Bolla MK, Liu J, et
al: MicroRNA Related Polymorphisms and Breast Cancer Risk. Plos
One. 9:e109973. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Michailidou K, Hall P, Gonzalez-Neira A,
Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J,
Bojesen SE, Bolla MK, et al: Large-scale genotyping identifies 41
new loci associated with breast cancer risk. Nat Genet. 45:353–361.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang L, Liu W, Jiang W, Lin J, Jiang Y, Li
B and Pang D: A miRNA binding site single-nucleotide polymorphism
in the 3′-UTR region of the IL23R gene is associated with breast
cancer. PLoS One. 7:e498232012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng H, Song F, Zhang L, Yang D, Ji P,
Wang Y, Almeida M, Calin GA, Hao X, Wei Q, et al: Genetic variants
at the miR-124 binding site on the cytoskeleton-organizing IQGAP1
gene confer differential predisposition to breast cancer. Int J
Oncol. 38:1153–1161. 2011.PubMed/NCBI
|
|
29
|
Wu H, Zhu S and Mo YY: Suppression of cell
growth and invasion by miR-205 in breast cancer. Cell Res.
19:439–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bartsch R, Ziebermayr R, Zielinski CC and
Steger GG: Triple-negative breast cancer. Wien Med Wochenschr.
160:174–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
